164 related articles for article (PubMed ID: 22792665)
1. Controlled substances bill biggest healthcare issue of session.
W V Med J; 2012; 108(3):102. PubMed ID: 22792665
[No Abstract] [Full Text] [Related]
2. Passage of a prescription drug abuse bill in the spring 2011 Nebraska unicameral.
Kreifels E
Nebr Nurse; 2011; 44(3):6. PubMed ID: 22013653
[No Abstract] [Full Text] [Related]
3. A pill problem: prescription drug abuse is the fastest growing form of substance abuse.
Hanson K
State Legis; 2010 Mar; 36(3):22-5. PubMed ID: 20306600
[No Abstract] [Full Text] [Related]
4. Va. doctors to report controlled substances. Program targets drugs with high potential for abuse, e.g., oxycontin, percocet.
Lubell J
Mod Healthc; 2006 Jun; 36(26):32. PubMed ID: 16841650
[No Abstract] [Full Text] [Related]
5. Excessive dispensing of controlled substances: a legal perspective.
Morgan WR
Ala Med; 1985 Feb; 54(8):13-7. PubMed ID: 3976450
[No Abstract] [Full Text] [Related]
6. Drinking the Pierian spring. Thoughts on things we ought to know.
Jimenez CC
W V Med J; 2010; 106(4 Spec No):4-7. PubMed ID: 21932746
[No Abstract] [Full Text] [Related]
7. New prescription drug abuse laws.
Howe CW
Mich Med; 1988 Aug; 87(8):463, 508. PubMed ID: 3193903
[No Abstract] [Full Text] [Related]
8. Prescription drug diversion: "what Lola wants, Lola gets".
Thomison JB
J Tenn Med Assoc; 1989 Jan; 82(1):35-7. PubMed ID: 2927111
[No Abstract] [Full Text] [Related]
9. Searching for answers: proper prescribing of controlled prescription drugs.
Brown ME; Swiggart WH; Dewey CM; Ghulyan MV
J Psychoactive Drugs; 2012; 44(1):79-85. PubMed ID: 22641969
[TBL] [Abstract][Full Text] [Related]
10. PADS approach to preventing prescription drug diversion.
Ambre JJ
NIDA Res Monogr; 1993; 131():141-4. PubMed ID: 8413524
[No Abstract] [Full Text] [Related]
11. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances.
Joranson DE
NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529
[No Abstract] [Full Text] [Related]
12. Prescription drug diversion.
Va Med Q; 1996; 123(2):132. PubMed ID: 8810894
[No Abstract] [Full Text] [Related]
13. Fighting prescription drug abuse in Arkansas.
Penn CL
J Ark Med Soc; 2013 Jun; 109(13):272-5. PubMed ID: 23808092
[No Abstract] [Full Text] [Related]
14. The Illinois experience in achieving the medical/regulatory balance required to control prescription drug diversion.
Bishop MT; Vlasty RJ
NIDA Res Monogr; 1993; 131():159-75. PubMed ID: 8413527
[No Abstract] [Full Text] [Related]
15. Bringing all the players to the table: the West Virginia Controlled Substance Advisory Board.
Hannah KL; O'Neil M
W V Med J; 2010; 106(4 Spec No):22-4. PubMed ID: 21932749
[TBL] [Abstract][Full Text] [Related]
16. Prescription drug use and abuse.
Meadows M
FDA Consum; 2001; 35(5):18-24. PubMed ID: 11697087
[No Abstract] [Full Text] [Related]
17. The Medicaid Prescription Drug Initiative.
Roslewicz TD
NIDA Res Monogr; 1993; 131():200-5. PubMed ID: 8413531
[No Abstract] [Full Text] [Related]
18. Arkansas prescription monitoring program implemented.
Robertson D
J Ark Med Soc; 2013 Jun; 109(13):278-9. PubMed ID: 23808093
[No Abstract] [Full Text] [Related]
19. New York State's Triplicate Prescription Program.
Eadie JL
NIDA Res Monogr; 1993; 131():176-93. PubMed ID: 8413528
[No Abstract] [Full Text] [Related]
20. An American Medical Association perspective on preventing prescription drug diversion.
Ambre JJ
NIDA Res Monogr; 1993; 131():224-7. PubMed ID: 8413533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
